Erratum: Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor (Biochemical and Biophysical Research Communications (2005) 335 (523-528) DOI: 10.1016/j.bbrc.2005.07.113);Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor

Biochemical and Biophysical Research Communications

Volumn 335, Issue 2, 2005, Pages 523-528

  Yang, Shi Xin ^a   Chen, Jian Hong ^a   Jiang, Xiu Feng ^a   Wang, Qing Liang ^a   Chen, Zi Qiang ^a   Zhao, Wen ^a   Feng, Yu Hui ^a   Xin, Rong ^a   Shi, Jing Quan ^a   Bian, Xiu Wu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Chemokine receptor CXCR4; Glioma; Vascular endothelial growth factor

Indexed keywords

CHEMOKINE RECEPTOR CCR4; VASCULOTROPIN;

ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 23744481199     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.016     Document Type: Erratum

References (21)

1. X.W. Bian, J.H. Chen, X.F. Jiang, J.S. Bai, and X. Zhang Angiogenesis as an immunopharmacologic target in inflammation and cancer Int. Immunopharmacol. 4 2004 1537 1547
2. J.N. Scott, N.B. Rewcastle, P.M. Brasher, D. Fulton, N.A. Hagen, J.A. MacKinnon, G. Sutherland, J.G. Cairncross, and P. Forsyth Long-term glioblastoma multiforme (GBM) survivors: a population-based study Can. J. Neurol. Sci. 25 1998 197 201
3. B.T. Suratt, J.M. Petty, S.K. Young, K.C. Malcolm, J.G. Lieber, J.A. Nick, J.A. Gonzalo, P.M. Henson, and G.S. Worthen Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis Blood 104 2004 565 571
4. J.M. Wang, X.Y. Deng, W. Gong, and S.B. Su Chemokines and their role in tumor growth and metastasis J. Immunol. Methods 220 1998 1 17
5. F. Balkwill The significance of cancer cell expression of the chemokine receptor CXCR4 Semin. Cancer Biol. 14 2004 171 179
6. Y. Zhou, P.H. Larsen, C. Hao, and V.W. Yong CXCR4 is a major chemokine receptor on glioma cells and mediates their survival J. Biol. Chem. 277 2002 49481 49487
7. T.B. Huber, H.C. Reinhardt, M. Exner, J.A. Burger, D. Kerjaschki, M.A. Saleem, and H. Pavenstadt Expression of functional CCR and CXCR chemokine receptors in podocytes J. Immunol. 168 2002 6244 6252
8. Y. Zhou, X. Bian, Y. Le, W. Gong, X. Zhang, L. Wang, P. Iribarren, R. Salcedo, O.M. Howard, W. Farrar, and J.M. Wang Formylpeptide receptor FPR and the rapid growth of malignant human glioma J. Natl. Cancer Inst. 97 2005 823 835
9. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow Lancet 357 2001 539 545
10. P.M. Murphy Chemokines and molecular basis of cancer metastasis N. Engl. J. Med. 354 2001 833 835
11. E. Oberlin, A. Amara, and F. Bachelerie The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 Nature 382 1996 833 835
12. J. Hu, X. Deng, X. Bian, G. Li, Y. Tong, Y. Li, Q. Wang, R. Xin, X. He, G. Zhou, P. Xie, Y. Li, J.M. Wang, and Y. Cao The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma Clin. Cancer Res. 11 2005 4658 4665
13. Z. Liang, T. Wu, H. Lou, X. Yu, R.S. Taichman, S.K. Lau, S. Nie, B.J. Umbreit, and H. Shim Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4 Cancer Res. 64 2004 4302 4308
14. C.C. Bleul, R.C. Fuhlbrigge, and J.M. Casasnovas A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) J. Exp. Med. 184 1996 1101 1109
15. K. Tachibana, S. Hirota, H. Iizasa, H. Yoshida, K. Kawabata, Y. Kataoka, Y. Kitamura, K. Matsushima, N. Yoshida, S. Nishikawa, T. Kishimoto, and T. Nagasawa The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract Nature 393 1998 591 594
16. Q. Ma, D. Jones, and P.R. Borghesani Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice Proc. Natl. Acad. Sci. USA 95 1998 9448 9453
17. D.T. Shima, A.P. Adamis, N. Ferrara, K.T. Yeo, T.K. Yeo, R. Allende, J. Folkman, and P.A. D'Amore Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen Mol. Med. 1 1995 182 193
18. P. Carmeliet, and D. Collen Molecular basis of angiogenesis. Role of VEGF and VE-cadherin Ann. N. Y. Acad. Sci. 902 2000 249 262 discussion 262-264
19. P. Borgstrom, M.A. Bourdon, K.J. Hillan, P. Sriramarao, and N. Ferrara Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo Prostate 35 1998 1 10
20. L.E. Benjamin, and E. Keshet Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal Proc. Natl. Acad. Sci. USA 94 1997 8761 8766
21. L.A. Liotta, and E.C. Kohn The microenvironment of the tumour-host interface Nature 411 2001 375 379